Total Liabilities Summary of ImmuPharma plc

ImmuPharma plc's latest annual total liabilities in 2023 was 1.66 Million GBP , up 14.73% from previous year.
ImmuPharma plc's latest quarterly total liabilities in 2024 Q2 was 1.37 Million GBP , down 0.0% from previous quarter.
ImmuPharma plc reported annual total liabilities of 1.45 Million GBP in 2022, down -8.39% from previous year.
ImmuPharma plc reported annual total liabilities of 1.58 Million GBP in 2021, up 25.65% from previous year.
ImmuPharma plc reported quarterly total liabilities of 1.37 Million GBP for 2024 Q2, down 0.0% from previous quarter.
ImmuPharma plc reported quarterly total liabilities of 1.66 Million GBP for 2023 Q3, up 7.35% from previous quarter.

Annual Total Liabilities Chart of ImmuPharma plc (2023 - 2003)

Historical Annual Total Liabilities of ImmuPharma plc (2023 - 2003)

Year	Total Liabilities	Total Liabilities Growth
2023	1.66 Million GBP	14.73%
2022	1.45 Million GBP	-8.39%
2021	1.58 Million GBP	25.65%
2020	1.26 Million GBP	137.07%
2019	531.86 Thousand GBP	-48.6%
2018	1.03 Million GBP	-28.28%
2017	1.44 Million GBP	23.97%
2016	1.16 Million GBP	-23.57%
2015	1.52 Million GBP	11.39%
2014	1.36 Million GBP	-24.12%
2013	1.8 Million GBP	-13.87%
2012	2.09 Million GBP	17.97%
2011	1.77 Million GBP	12.07%
2010	1.58 Million GBP	-75.88%
2009	6.56 Million GBP	203.42%
2008	2.16 Million GBP	105.9%
2007	1.05 Million GBP	-27.03%
2006	1.43 Million GBP	28.14%
2005	1.12 Million GBP	7921.43%
2004	14 Thousand GBP	600.0%
2003	2000.00 GBP	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	1.37 Million GBP	-17.64%
2024 Q2	1.37 Million GBP	0.0%
2023 Q3	1.66 Million GBP	7.35%
2023 Q1	1.55 Million GBP	6.87%
2023 Q2	1.55 Million GBP	0.0%
2023 Q4	1.66 Million GBP	0.0%
2023 FY	1.66 Million GBP	14.73%
2022 Q1	858.52 Thousand GBP	-45.81%
2022 Q2	858.52 Thousand GBP	0.0%
2022 Q3	1.45 Million GBP	69.05%
2022 Q4	1.45 Million GBP	0.0%
2022 FY	1.45 Million GBP	-8.39%
2021 FY	1.58 Million GBP	25.65%
2021 Q4	1.58 Million GBP	0.0%
2021 Q1	1.77 Million GBP	40.39%
2021 Q2	1.77 Million GBP	0.0%
2021 Q3	1.58 Million GBP	-10.5%
2020 Q2	2.1 Million GBP	0.0%
2020 FY	1.26 Million GBP	137.07%
2020 Q4	1.26 Million GBP	0.0%
2020 Q1	2.1 Million GBP	295.47%
2020 Q3	1.26 Million GBP	-40.05%
2019 Q4	531.86 Thousand GBP	0.0%
2019 Q2	541.35 Thousand GBP	0.0%
2019 FY	531.86 Thousand GBP	-48.6%
2019 Q3	531.86 Thousand GBP	-1.75%
2019 Q1	541.35 Thousand GBP	-47.68%
2018 Q3	1.03 Million GBP	10.49%
2018 Q2	936.45 Thousand GBP	0.0%
2018 FY	1.03 Million GBP	-28.28%
2018 Q1	936.45 Thousand GBP	-35.09%
2018 Q4	1.03 Million GBP	0.0%
2017 Q4	1.44 Million GBP	0.0%
2017 Q3	1.44 Million GBP	81.09%
2017 Q2	796.69 Thousand GBP	0.0%
2017 FY	1.44 Million GBP	23.97%
2017 Q1	796.69 Thousand GBP	-31.54%
2016 Q4	1.16 Million GBP	0.0%
2016 FY	1.16 Million GBP	-23.57%
2016 Q1	1.16 Million GBP	-23.47%
2016 Q3	1.16 Million GBP	-0.13%
2016 Q2	1.16 Million GBP	0.0%
2015 Q3	1.52 Million GBP	75.73%
2015 FY	1.52 Million GBP	11.39%
2015 Q2	866.45 Thousand GBP	0.0%
2015 Q1	866.45 Thousand GBP	-36.61%
2015 Q4	1.52 Million GBP	0.0%
2014 Q1	3.64 Million GBP	102.48%
2014 Q2	3.64 Million GBP	0.0%
2014 Q3	1.36 Million GBP	-62.52%
2014 Q4	1.36 Million GBP	0.0%
2014 FY	1.36 Million GBP	-24.12%
2013 FY	1.8 Million GBP	-13.87%
2013 Q1	1.49 Million GBP	-28.37%
2013 Q2	1.49 Million GBP	0.0%
2013 Q3	1.8 Million GBP	20.25%
2013 Q4	1.8 Million GBP	0.0%
2012 Q3	2.09 Million GBP	72.14%
2012 Q4	2.09 Million GBP	0.0%
2012 FY	2.09 Million GBP	17.97%
2012 Q2	1.21 Million GBP	0.0%
2011 Q4	1.77 Million GBP	0.0%
2011 FY	1.77 Million GBP	12.07%
2011 Q2	1.45 Million GBP	0.0%
2010 Q2	4.89 Million GBP	0.0%
2010 FY	1.58 Million GBP	-75.88%
2010 Q4	1.58 Million GBP	0.0%
2009 Q2	6.81 Million GBP	0.0%
2009 Q4	6.56 Million GBP	0.0%
2009 FY	6.56 Million GBP	203.42%
2008 FY	2.16 Million GBP	105.9%
2008 Q4	2.16 Million GBP	0.0%
2008 Q2	728 Thousand GBP	0.0%
2007 Q2	1.25 Million GBP	0.0%
2007 FY	1.05 Million GBP	-27.03%
2007 Q4	1.04 Million GBP	0.0%
2006 Q1	1.12 Million GBP	0.0%
2006 FY	1.43 Million GBP	28.14%
2005 Q3	11 Thousand GBP	0.0%
2005 FY	1.12 Million GBP	7921.43%
2005 Q1	14 Thousand GBP	0.0%
2004 FY	14 Thousand GBP	600.0%
2004 Q3	8000.00 GBP	0.0%
2004 Q1	2000.00 GBP	0.0%
2003 Q3	- GBP	0.0%
2003 FY	2000.00 GBP	0.0%

Peer Total Liabilities Comparison of ImmuPharma plc

Name	Total Liabilities	Total Liabilities Difference

Global Stocks Search

ImmuPharma plc (IMM.L)

Total Liabilities Summary of ImmuPharma plc

Annual Total Liabilities Chart of ImmuPharma plc (2023 - 2003)

Historical Annual Total Liabilities of ImmuPharma plc (2023 - 2003)

Peer Total Liabilities Comparison of ImmuPharma plc